Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Harefuah|October 30, 2001
[Hepatic and hematological complications following ecstasy usage]O Shibolet, Y Kalish, S Gillis, et al.Refu'At Ha-Peh Veha-Shinayim (1993)|July 14, 2010
[Dental management of patients using anti agregant drugs: background, risks and clinical guidelines]N Givol, A HalkinEchocardiography (Mount Kisco, N.Y.)|April 27, 2001
Catheter-delivered ultrasound therapy for native coronary arterial thrombosis and occluded saphenous vein graftsA Halkin, U RosenscheinThe Cochrane Database of Systematic Reviews|January 28, 2005
Cyclosporine A for induction of remission in severe ulcerative colitisO Shibolet, E Regushevskaya, M Brezis, et al.Heart (British Cardiac Society)|July 16, 2004
Late incomplete lesion coverage following Cypher stent deployment for diffuse right coronary artery stenosisA Halkin, S Carlier, M B LeonJournal of Thrombosis and Thrombolysis|December 1, 2001
Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarctionA Halkin, A Roth, M Jonas, et al.FEMS Immunology and Medical Microbiology|May 1, 1997
Shiga toxin induces medullary tubular injury in isolated perfused rat kidneysO Shibolet, A Shina, S Rosen, et al.QJM : Monthly Journal of the Association of Physicians|July 17, 1998
Likelihood ratios: getting diagnostic testing into perspectiveA Halkin, J Reichman, M Schwaber, et al.QJM : Monthly Journal of the Association of Physicians|April 11, 2009
Incidence and prognosis of non-Q-wave vs. Q-wave myocardial infarction following catheter-based reperfusion therapyA Halkin, D Fourey, A Roth, et al.European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginoneA Nagler, M Ohana, O Shibolet, et al.Pageof 3